// App-Quantinova.ai

1429 : Markers for Increased Thrombotic Risk within the Complete Blood Count

Researchers

Presenter

  • Sigrun H. Lund

Principal Investigators

  • Malin Hultcrantz

  • Signy Vala Sveinsdottir

  • Guony Eiriksdottir

  • Tamara B Harris

  • Vilmundur Guonason

  • Sigurdur Y Kristinsson

Medical Centers

  • Faculty of Medicine, Univ of Iceland, Reykjavik, Iceland

  • National Institute on Aging, National Institutes of Health, Baltimore, MD.

  • Department of Oncology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

  • pavogur, Iceland

  • Department of Endocrinology, Landspitali University Hospital, Reykjavik, Iceland

  • The Icelandic Heart Association, Ka

  • Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

Locations

  • United States

  • Sweden

  • Iceland

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetes

  • Venous thrombosis

  • Hypertension

Biomarkers

  • N-Acylethanolamine acid amidase

  • White Blood Cell

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved